Azithromycin Plus Hydroxychloroquine for COVID-19 Infection

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 8, 2021

Primary Completion Date

August 26, 2021

Study Completion Date

August 26, 2021

Conditions
Respiratory Tract Infection Viral
Interventions
DRUG

Azithromycin plus hydroxychloroquine

All patients will receive active comparator. One group will receive placebo on D1-3 followed by active comparator D4-9, while the other group will receive active comparator D1-6 followed by placebo D7-9.

Trial Locations (1)

06708

Waterbury Hospial, Waterbury

All Listed Sponsors
collaborator

Waterbury Hospital

UNKNOWN

lead

Iterum Therapeutics, International Limited

INDUSTRY